Paper Details

  1. Home
  2. Paper Details

A randomized pilot study of MOtiVation and Enhancement (MOVE) Training for negative symptoms in schizophrenia.

Author: BrownMatt, LiXueying, MaplesNatalie, MedellinElisa, MintzJim, RobertsDavid, VelliganDawn I

AddressRefers to the affiliation address of the author associated with a paper or article. This may include information such as the name of the institution or university where the author conducted the research, department, postal code, and country. This information is useful when evaluating the credibility of a paper or when tracking research activities in a specific field or region.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, N.I.H., ExtramuralResearch funding provided by the NIH to external research institutions and researchers.

Overview

This research focuses on persistent and clinically significant negative symptoms (PNS) in schizophrenia. PNS significantly impact quality of life and functional outcomes, but current treatments are limited. The study highlights the need for new treatment models addressing the full spectrum of PNS.
Paper Details　
Original Abstract of the Article :
Among individuals with schizophrenia, those who have persistent and clinically significant negative symptoms (PNS) have the poorest functional outcomes and quality of life. The NIMH-MATRICS Consensus Statement indicated that these symptoms represent an unmet therapeutic need for large numbers of ind...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/25937461

データ提供：米国国立医学図書館（NLM）

MOVE Training for Negative Symptoms in Schizophrenia: A Beacon in the Desert of Mental Illness

Schizophrenia, a complex and challenging mental illness, can feel like navigating a vast and unforgiving desert. This study explores the potential of a new psychosocial treatment model, MOtiVation and Enhancement (MOVE) Training, to address the debilitating negative symptoms often associated with schizophrenia. The researchers conducted a randomized pilot study to assess the effectiveness of MOVE training in reducing these symptoms. The study highlights the unmet therapeutic needs of patients with schizophrenia, particularly those with persistent and clinically significant negative symptoms (PNS).

A Desert of Negative Symptoms

Negative symptoms, like mirages in a desert, can be elusive and difficult to address. This study offers hope for patients with schizophrenia, exploring a novel approach to managing these challenging symptoms.

A Desert of Hope

The development of new psychosocial treatment models offers a beacon of hope for patients with schizophrenia. MOVE Training, with its focus on motivation and enhancement, provides a potential pathway for improved functional outcomes and quality of life.

Dr.Camel's Conclusion

The desert of schizophrenia is a complex and challenging landscape. This research offers a glimmer of hope for patients grappling with negative symptoms, exploring a novel approach to treatment. MOVE Training, like a wellspring in the desert, may offer a source of relief and improvement for those struggling with this debilitating condition.

Date :
  1. Date Completed 2016-02-22
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

25937461

DOI: Digital Object Identifier

NIHMS681949

Related Literature

Article Analysis
・Effective treatment of schizophrenia
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.